Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: A case report

International Psychogeriatrics

Volumn 17, Issue 2, 2005, Pages 313-318

  Rosin, Richard A ^a,c   Raskind, Murray A ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Aggressive behavior; Agitation; Hormonal therapy; LHRH analogue; Psychotropic

Indexed keywords

DIETHYLSTILBESTROL; GABAPENTIN; GONADORELIN AGONIST; GOSERELIN; OLANZAPINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; TRAZODONE; VALPROIC ACID;

AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BRADYKINESIA; CASE REPORT; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; GAIT DISORDER; HUMAN; HYPOTENSION; MALE; MUSCLE RIGIDITY; NURSING HOME; SEDATION; SIDE EFFECT;

AGED; AGGRESSION; ALZHEIMER DISEASE; AMINES; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CYCLOHEXANECARBOXYLIC ACIDS; DIBENZOTHIAZEPINES; GAMMA-AMINOBUTYRIC ACID; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; MALE; PROPRANOLOL; RISPERIDONE; TESTOSTERONE; TRAZODONE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 23044489607     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610205001614     Document Type: Article

References (22)

1. Aromaki, A. S., Lindman, R. E. and Eriksson, C. J. P. (1999). Testosterone, aggressiveness and antisocial personality. Aggressive Behavior, 25, 113-123.
2. Bjork, J. M., Moeller, F. G., Dougherty, D. M. and Swann, A. C. (2001). Endogenous plasma testosterone levels and commission errors in women: a preliminary report. Physiology and Behavior, 73, 217-221.
3. Briken, P., Hill, A. and Berner, W. (2003). Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review. Journal of Clinical Psychiatry, 64, 890-897.
4. British National Formulary. 45 March 2003 sec 6.4.1 352-353.
5. British National Formulary. 45 March 2003 sec 8.3.4 435.
6. Brooks, J. H. and Reddon, J. R. (1996). Serum testosterone in violent and nonviolent offenders. Journal of Clinical Psychology, 52, 475-483.
7. Cohen-Mansfield, J., Marx, M. S. and Rosenthal, A. S. (1989). A description of agitation in a nursing home. Journal of Gerontology, 44, M77-M84.
8. Ehrenkranz, J., Bliss, E. and Sheard, M. H. (1974). Plasma testosterone correlation with aggressive behavior and social dominance in man. Psychosomatic Medicine, 36, 469-474.
9. Kreuz, L. E. and Rose, R. M. (1972). Assessment of aggressive behavior and plasma testosterone in a young criminal population. Psychosomatic Medicine, 34, 321-332.
10. Kyomen, H. H., Hennen, J., Gottleib, G. L. and Wei, J. Y. (2002). Estrogen therapy and noncognitive psychiatric signs and symptoms in elderly patients with dementia. American Journal of Psychiatry, 159, 1225-1227.
11. Kyomen, H. H., Nobel, K. W. and Wei, J. Y. (1991). The use of estrogen to decrease aggressive physical behavior in elderly men with dementia. Journal of the American Geriatrics Society, 39, 1110-1112.
12. Kyomen, H. H., Satlin, A., Hennen, J. and Wei, J. Y. (1999). Estrogen therapy and aggressive behavior in elderly patients with moderate to severe dementia - results from a short-term, randomized, double-blind trial. American Journal of Geriatric Psychiatry, 4, 339-348.
13. O'Connor, D. B., Archer, J., Hair, W. M. and Wu, F. C. (2002). Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men. Physiology and Behavior, 75, 557-566.
14. Perry, P. J., Kutscher, E. C., Lund, B. C., Yates, W. R., Holman, T. L. and Demers, L. J. (2003). Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. Journal of Forensic Science, 48, 646-651.
15. Raskind, M. A. and Barnes, R. F. (2002). Alzheimer's disease: treatment of noncognitive behavioral abnormalities. In K. Davis, D. Charney, J. Coyle and C. Nemeroff (Eds.) Psychopharmacology: the Fifth Generation of Progress (pp. 1253-1265) New York: American College of Neuropsychopharmacology, Lippincott Williams and Wilkins.
16. Soler, H., Vinayak, P. and Quadagno, D. (2000). Biosocial aspects of domestic violence. Psychoneuroendocrinology, 25, 721-739.
17. Steele, C., Rovner, B. W., Chase, G. A. and Folstein M. (1990). Psychiatric symptoms and nursing-home placement in Alzheimer's disease. American Journal of Psychiatry, 147, 1049-1051.
18. Streim, J. E., Rovner, B. W. and Katz, I. R. (1996). Psychiatric aspects of nursing home care. In Comprehensive Review of Geriatric Psychiatry (2nd ed.) (pp. 910). Washington, DC: American Psychiatric Association Press.
19. Teeter, R. B. et al. (1976). Psychiatric disturbances of aged patients in skilled nursing homes. American Journal of Psychiatry, 133, 1430-1434.
20. Thomas, A. J. and O'Brien, J. T. (2002). Clinical aspects of dementia: Alzheimer's disease. In R. Jacoby and C. Oppenheimer (Eds.) Psychiatry in the Elderly. (3rd ed.) (pp. 517). Oxford: Oxford University Press.
21. Ziutsmann, M. and Nieschlagg, E. (2001). Testosterone levels in healthy men and the relation to behavioral and physical characteristics: facts and constructs. European Journal of Endocrinology, 144, 183-197.
22. Zornberg, G. L. and Jick, H. (2000) Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet, 356, 1219-1223.